GE Healthcare has invested $5m CardioDx, a privately-held company specialising in cardiovascular genomic diagnostics. The move is consistent with the company's strategy to expand out of in vivo and into in vitro diagnostics. The news, announced today, also marks the first investment for ...
Please Login to read the full article.
